What is the maximum recommended dose of Reglan (metoclopramide) for a breastfeeding female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Reglan (Metoclopramide) Dosing for Breastfeeding Women

The maximum recommended dose of metoclopramide for breastfeeding women is 10 mg three times daily (30 mg total daily dose), which is both safe and compatible with breastfeeding. 1, 2

Standard Dosing Protocol

  • Typical dose: 10 mg orally three times daily for lactation enhancement 3, 4
  • Maximum daily dose: 30 mg per day (10 mg three times daily) 1
  • Duration: Generally recommended for 4-12 weeks maximum, though often prescribed for 10-14 days initially 3, 5

Safety Profile in Breastfeeding

  • Metoclopramide is explicitly compatible with use in lactating women and is FDA-approved (unlike domperidone in the United States) 2, 6
  • The medication may actually increase milk supply, as it functions as a galactagogue by raising maternal serum prolactin levels 1, 2, 3
  • Important consideration: Ensure the mother has access to a breast pump if there is any delay in feeding her infant, as increased milk production may occur before the infant can effectively remove the milk 1, 2

Dose-Response Evidence

Research demonstrates clear dose-response relationships for lactation enhancement: 3

  • 5 mg three times daily: Did not significantly stimulate prolactin or milk secretion
  • 10 mg three times daily: Increased breast milk by 42.5 ml per feed with significant prolactin elevation
  • 15 mg three times daily: Increased breast milk by 50.0 ml per feed

However, the 10 mg three times daily dose (30 mg total) remains the recommended maximum to minimize adverse effects while maintaining efficacy. 1, 3

Side Effects and Monitoring

Common adverse reactions at standard doses include: 1, 5

  • Restlessness, drowsiness, fatigue, and lassitude
  • Diarrhea and muscle weakness
  • Potential dystonic reactions (rare at recommended doses)

Critical warning: The risk of tardive dyskinesia with metoclopramide is approximately 0.1% per 1000 patient-years when used appropriately, far lower than previously estimated 7

Higher risk groups requiring extra caution include: 7

  • Elderly females
  • Diabetic patients
  • Those with liver or kidney failure
  • Patients on concomitant antipsychotic medications

Clinical Algorithm Before Prescribing

Before initiating metoclopramide, optimize non-pharmacologic interventions: 2

  • Frequent feeding or pumping (8-12 times per 24 hours)
  • Proper latch assessment and correction
  • Adequate maternal hydration and nutrition

Exclude medical causes of low milk supply: 2

  • Retained placental fragments
  • Thyroid dysfunction
  • Insufficient glandular tissue

Practical Administration

  • Metoclopramide can be given orally or intravenously (10 mg IV) 1
  • When used as an antiemetic adjunct (different indication), dosing is 10 mg IV or orally 20-30 minutes before other medications 1
  • No need to interrupt breastfeeding or pump and discard milk when taking metoclopramide at recommended doses 1, 6

Duration Limitations

  • Oral preparations are recommended for 4-12 weeks of therapy maximum 5
  • Parenteral metoclopramide should be limited to 1-2 days 5
  • Long-term use at doses exceeding 10 mg 3-4 times daily increases risk of tardive dyskinesia and should be avoided 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metoclopramide for Lactation Enhancement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial.

Archives of disease in childhood. Fetal and neonatal edition, 2012

Research

Metoclopramide: a dopamine receptor antagonist.

American family physician, 1990

Guideline

Safe Postpartum Medications for Breastfeeding Mothers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.

Neurogastroenterology and motility, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.